Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000464450 | SCV000547553 | likely benign | Colorectal cancer, susceptibility to, 10 | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000564396 | SCV000671063 | likely benign | Hereditary cancer-predisposing syndrome | 2021-08-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001311899 | SCV001819350 | likely benign | not provided | 2021-03-09 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as germline pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 29056344, 27093186) |
Sema4, |
RCV000564396 | SCV002534596 | likely benign | Hereditary cancer-predisposing syndrome | 2021-04-05 | criteria provided, single submitter | curation | |
Prevention |
RCV003970284 | SCV004783530 | likely benign | POLD1-related condition | 2023-07-09 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |